Search for: "Teva Branded Pharmaceutical Products R"
Results 21 - 40
of 96
Sorted by Relevance
|
Sort by Date
5 May 2014, 8:28 am
Unfortunately for Actavis, on April 28, 2014, the FDA awarded sole exclusivity on generic Celebrex® to Teva Pharmaceutical Industries Ltd. [read post]
13 Feb 2015, 12:00 pm
AstraZeneca markets and sells pharmaceutical products in the United States, including a drug sold under the trade name Nexium. [read post]
22 Nov 2019, 6:59 am
It means that companies are often paid many times above the costs of production and should be incentivised to undertake further innovation. [read post]
19 Mar 2012, 1:31 am
By Kurt R. [read post]
13 Jun 2011, 5:32 pm
By Kurt R. [read post]
18 Jan 2013, 2:06 pm
. are safer taking brand-name drugs. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
8 May 2020, 6:57 pm
Eagle suedSlayback Pharma LLC for infringing four patents coveringEagle’s brand name bendamustine pharmaceutical product. [read post]
26 Mar 2024, 7:01 pm
Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book.… [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow generic companies… [read post]
20 Nov 2008, 8:29 pm
Note that financial support for this white paper was provided by Teva Pharmaceuticals. [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch) [read post]
23 Jun 2011, 11:16 pm
"FDA-approved generic drugs must meet rigorous standards and are required to be of high quality so that people can be assured that their medications will act the same in the body as the brand-name product. [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
